Investigating Connexin 43's role in heart issues related to Duchenne muscular dystrophy
Connexin 43: a new player in Duchenne muscular dystrophy associated cardiomyopathy
This study is looking at how a protein called Connexin 43 affects heart health in people with Duchenne muscular dystrophy, with the goal of finding new ways to help prevent heart problems like arrhythmias and heart failure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11132829 on NIH RePORTER |
What this research studies
This research focuses on understanding how a protein called Connexin 43 (Cx43) contributes to heart problems in patients with Duchenne muscular dystrophy (DMD). The study aims to explore how changes in Cx43 affect heart cell function and lead to arrhythmias and heart failure. By examining the relationship between Cx43 and the microtubule network in heart cells, researchers hope to identify new therapeutic targets that could improve heart health in DMD patients. The approach involves detailed analysis of heart cell behavior and the molecular mechanisms at play.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Duchenne muscular dystrophy who are experiencing or at risk for heart complications.
Not a fit: Patients without Duchenne muscular dystrophy or those who do not have heart-related issues associated with the condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve heart function and reduce the risk of heart failure in patients with Duchenne muscular dystrophy.
How similar studies have performed: Previous research has shown promising results in targeting similar molecular pathways to improve heart function in other conditions, suggesting potential for success in this novel approach.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Fraidenraich, Diego — Rutgers Biomedical and Health Sciences
- Study coordinator: Fraidenraich, Diego
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.